Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Olive Oil

Fatty-acidEdible oil

Extra-virgin olive oil is the most rigorously studied edible oil for cardiovascular outcomes. The PREDIMED RCT showed a Mediterranean diet enriched with ≥4 tablespoons/day of EVOO reduced major cardiovascular events by ~30% in high-risk adults. Most of the benefit comes from displacing saturated fat and refined carbs in the broader diet — not from olive oil acting as an isolated supplement.

Quick decision guide

May help most

Adults at elevated cardiovascular risk who can use EVOO to replace butter, margarine, refined seed oils, or saturated-fat cooking fats within a broadly Mediterranean-style eating pattern.

Common dosing range

2–4 tablespoons (30–60 g) per day of high-quality extra-virgin olive oil, used in cooking and dressings — replacing other fats rather than added on top.

When to expect effects

Lipid markers (LDL oxidation, HDL function) move over weeks; clinical CV events accrue over years.

Watch out for

Calorie-dense at ~120 kcal per tablespoon. Don't add olive oil on top of an otherwise high-calorie Western diet expecting magic.

Evidence snapshot

CV events in high-risk adults (within Med diet)Strong
LDL cholesterol oxidation protection (polyphenols)Moderate
All-cause mortality (observational)Moderate
Blood pressureLow–Moderate

What is it

Olive oil is the edible oil expressed mechanically from the fruit of Olea europaea and a defining component of the Mediterranean diet. Its fatty-acid profile is dominated by oleic acid (a monounsaturated omega-9 fatty acid, typically 55-83% by weight), with smaller fractions of palmitic, linoleic, and stearic acids. Extra-virgin olive oil (EVOO) additionally contains polyphenols - notably oleocanthal, oleuropein, hydroxytyrosol, and tyrosol - and minor constituents including squalene, tocopherols (vitamin E), and phytosterols, which collectively contribute to its antioxidant capacity and the distinct sensory profile (pungency, bitterness) regulated by European trade standards.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You're currently cooking with butter, lard, palm oil, or refined seed oils and could swap to EVOO
You have elevated cardiovascular risk (family history, hypertension, diabetes, prior event) and a clinician has flagged diet
You eat a Mediterranean-style pattern (fish, vegetables, legumes, whole grains) — EVOO is the most evidence-backed fat to layer in
You want a dietary lever that has actual hard-endpoint RCT data, not just biomarker movement

Probably skip if

You're treating olive oil as a 'health supplement' to take by the spoonful on top of your existing diet — those calories add up fast
You're swapping fish, nuts, or vegetables FOR olive oil rather than using it as a cooking fat replacement
You're buying ultra-cheap 'olive oil' or 'pure olive oil' (not extra-virgin) and expecting the polyphenol benefits — refined oils contain very little hydroxytyrosol
You're hoping EVOO compensates for an otherwise high-saturated-fat / high-refined-carb diet

Evidence at a glance

Cardiovascular disease prevention (within Mediterranean diet)

Strong Evidence
Effect
HR 0.69 (95% CI 0.53–0.91) for major CV events; ~30% relative risk reduction over ~5 years in high-risk adults
Best fit
Adults with established cardiovascular risk factors who are willing to shift toward a Mediterranean-style eating pattern
Time
Years for clinical CV event reduction

LDL cholesterol oxidation and lipid profile

Good Evidence
Effect
Reduction in oxidised LDL biomarkers; modest LDL-C decrease (~3–5 mg/dL) when displacing saturated fat
Best fit
Adults choosing high-polyphenol EVOO over refined oils or saturated fats
Time
Weeks for biomarker changes

All-cause and cardiovascular mortality

Good Evidence
Effect
Per 10 g/day EVOO: ~7% lower all-cause mortality, ~10% lower CV mortality (observational)
Best fit
Adults consuming EVOO regularly as part of overall dietary pattern
Time
Years

Type 2 diabetes — glycaemic control and risk reduction

Good Evidence
Effect
~40% relative reduction in new-onset T2D in PREDIMED EVOO arm vs control
Best fit
Adults with prediabetes or metabolic syndrome adopting a Mediterranean pattern
Time
Months to years

Blood pressure

Limited Evidence
Effect
~1–3 mmHg systolic BP reduction
Best fit
Adults with mild BP elevation as part of lifestyle approach
Time
Weeks to months

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Cardiovascular disease prevention (within Mediterranean diet)

Supplement benefit
Strong Evidence

PREDIMED is the strongest dietary RCT ever published for a single food. 7,447 high-CV-risk Spanish adults were randomized to a Mediterranean diet plus free EVOO (~50 g/day), a Mediterranean diet plus mixed nuts, or a low-fat control. After ~5 years, the EVOO arm had ~30% fewer major CV events (HR 0.69, 95% CI 0.530.91). The benefit is from the diet pattern, with EVOO as the dominant added-fat componentnot from olive oil in isolation.

Effect size
HR 0.69 (95% CI 0.53–0.91) for major CV events; ~30% relative risk reduction over ~5 years in high-risk adults
Time to effect
Years for clinical CV event reduction
Best fit
Adults with established cardiovascular risk factors who are willing to shift toward a Mediterranean-style eating pattern
Less likely
Already eating a low-saturated-fat, high-vegetable diet — incremental benefit is smaller

Bottom line: The single best RCT evidence for any food-as-supplement on hard cardiac endpoints. Use it as a cooking fat replacement within a Mediterranean pattern, not in addition.

LDL cholesterol oxidation and lipid profile

Biomarker support
Good Evidence

Extra-virgin olive oil polyphenols (mainly hydroxytyrosol and oleuropein derivatives) reduce oxidative modification of LDL particles in mechanism studies and short-term RCTs. The EU has approved a regulated health claim: ≥5 mg HT-equivalents per 20 g olive oil 'contributes to the protection of blood lipids from oxidative stress.' Effects on LDL-C concentration itself are modest; the change is more about lipoprotein quality than quantity.

Effect size
Reduction in oxidised LDL biomarkers; modest LDL-C decrease (~3–5 mg/dL) when displacing saturated fat
Time to effect
Weeks for biomarker changes
Best fit
Adults choosing high-polyphenol EVOO over refined oils or saturated fats
Less likely
Users of refined ('pure' or 'light') olive oil — polyphenol content is much lower and the EU claim doesn't apply

Bottom line: EU-regulated health claim is real, but ONLY for unrefined extra-virgin product with adequate polyphenols. The cheap pale stuff doesn't count.

All-cause and cardiovascular mortality

Supplement benefit
Good Evidence

Within PREDIMED, each additional 10 g/day of extra-virgin olive oil intake was associated with 10% lower CV disease risk and 7% lower mortality risksignificant only in the EVOO arm of the trial. Large cohort studies (Nurses' Health, Health Professionals Follow-up Study) confirm an inverse dose-response between olive oil intake and mortality.

Effect size
Per 10 g/day EVOO: ~7% lower all-cause mortality, ~10% lower CV mortality (observational)
Time to effect
Years
Best fit
Adults consuming EVOO regularly as part of overall dietary pattern
Less likely
Users of refined olive oil only, or those treating olive oil as an isolated supplement

Bottom line: Real signal across multiple high-quality cohorts. Strongest when EVOO replaces less healthy fats rather than adding calories.

Type 2 diabetes — glycaemic control and risk reduction

Supplement benefit
Good Evidence

PREDIMED's secondary analyses showed a ~40% reduction in new-onset type 2 diabetes in the EVOO arm vs control. Adding EVOO improves postprandial glucose and insulin sensitivity in metabolic-syndrome cohorts. As with CV outcomes, the benefit is part of the diet pattern.

Effect size
~40% relative reduction in new-onset T2D in PREDIMED EVOO arm vs control
Time to effect
Months to years
Best fit
Adults with prediabetes or metabolic syndrome adopting a Mediterranean pattern
Less likely
People with established T2D using EVOO without other dietary changes

Bottom line: Strong PREDIMED signal for T2D prevention. Replace, don't add.

Blood pressure

Supplement benefit
Limited Evidence

Short-term RCTs and small meta-analyses show modest BP reductions (≈13 mmHg systolic) when EVOO replaces other fats. Effect is consistent in direction but small in magnitude; it doesn't replace a real antihypertensive when BP is significantly elevated.

Effect size
~1–3 mmHg systolic BP reduction
Time to effect
Weeks to months
Best fit
Adults with mild BP elevation as part of lifestyle approach
Less likely
Adults with stage 2 hypertension — needs medication

Bottom line: Small contribution. Useful as part of a DASH/Mediterranean approach; not a substitute for treating hypertension.

How to take it

1. Typical dose
• 2–4 tablespoons (30–60 g) per day of extra-virgin olive oil • Used in cooking, salad dressings, drizzled on cooked food • Aim to REPLACE other added fats (butter, margarine, refined seed oils), not add on top
2. Higher studied dose
PREDIMED participants in the EVOO arm received ~50 g/day (~3.5 tbsp). No clear additional benefit above ~60 g/day and calorie load becomes significant.
3. Timing
No special timing required. EVOO is heat-stable to medium-high temperatures (smoke point ~190–215°C / 375–420°F for premium oils); fine for sautéing and roasting. Save the most expensive high-polyphenol oils for finishing/raw use to preserve flavour and antioxidants.
4. With food
It is food. Use as a cooking fat or dressing.
5. Split dosing
Spread across meals — typical use as cooking oil naturally distributes it.
6. How long to try
Daily, long-term. Olive oil is a dietary staple, not a course of treatment. Re-evaluate at standard cardiovascular health checks.

What to track

Lipid panel (total cholesterol, HDL, LDL, triglycerides) annually or per usual schedule
Blood pressure
Whether you're truly replacing other fats or adding calories
Source/quality of the oil — adulteration with cheaper refined oils is widespread in the market

Bottom line: 2–4 tablespoons of high-quality extra-virgin olive oil daily, used as a replacement cooking fat within a Mediterranean-style diet. That's the entire formula PREDIMED tested.

5 commercial forms

Compare the main delivery options and what they’re best suited for.

Extra-virgin olive oil (EVOO)

The form with evidence

Mechanically extracted (no solvents, no heat above ~27°C) from the first pressing. Retains polyphenols (hydroxytyrosol, oleuropein, oleocanthal) responsible for the health-claim effects. The form used in PREDIMED.

Polyphenol content varies widely — buy by quality, not just label.

Virgin olive oil

Acceptable

Same mechanical extraction but slightly higher free fatty acid content (up to 2%) and lower flavour grading than EVOO. Still unrefined; retains most polyphenols.

Similar to EVOO with somewhat lower polyphenol levels.

Refined ('pure' or 'olive oil')

Avoid for health claims

Heat- and/or solvent-refined from lower-grade oils, then blended with a small amount of virgin oil for flavour. Lost most polyphenols. Fine as a neutral cooking oil but doesn't carry the cardiovascular evidence.

Polyphenols largely destroyed by refining.

Olive pomace oil

Industrial grade

Solvent-extracted from the leftover olive paste after pressing. Lowest grade; suitable for high-heat cooking but no health-claim relevance.

Negligible polyphenol content.

Olive leaf extract (oleuropein supplement)

Different category

Concentrated extract of olive LEAVES (not the oil) sold as capsules for blood pressure or immune support. Distinct evidence base from culinary olive oil; included here for disambiguation.

Not the same product as olive oil — evaluate independently.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

caloric load if added rather than substitutedrare contact dermatitis with topical usevery rare olive-pollen cross-reactive food reaction

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Olive oil is a safe culinary food during pregnancy and breastfeeding. Mediterranean diet patterns including EVOO are associated with favourable pregnancy outcomes.

Bottom line: Olive oil is a food, not a supplement, and has the safety profile of a food. The main 'risk' is paying premium prices for adulterated or low-polyphenol product.

Interactions

warfarinMinor

Olive oil itself doesn't meaningfully affect warfarin. Vitamin K content is low. If you significantly change your overall dietary fat or vegetable intake (typical of a Mediterranean switch), have your INR rechecked.

antihypertensive medicationsMinor

EVOO's small BP-lowering effect could marginally add to medication effects. Not clinically significant for most people; monitor if you're at risk of hypotension.

weight-loss medications / orlistatMinor

Orlistat blocks fat absorption — high olive oil intake can cause oily stools and steatorrhea. Reduce fat intake or space dosing.

Food sources

Extra-virgin olive oil, 1 tbsp

Amount
1 tbsp (13.5 g fat)
%DV
17%

Extra-virgin olive oil, 2 tbsp

Amount
2 tbsp (27 g fat)
%DV
35%

Whole olives, 10 medium green

Amount
~33 g (3.3 g fat)
%DV
4%

Whole olives, 10 medium black (kalamata)

Amount
~33 g (3.5 g fat)
%DV
5%

Mediterranean salad dressing (oil-based)

Amount
2 tbsp (~14 g fat)
%DV
18%

Hummus (olive-oil-rich)

Amount
2 tbsp (~3 g fat)
%DV
4%

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

'Extra-virgin olive oil' on the label (NOT 'pure', 'light', 'olive oil' alone — those are refined)
Dark glass bottle or tin — protects polyphenols from light degradation
Harvest date or 'best by' within 18 months of harvest — polyphenols decline with time
Single country of origin (Spain, Italy, Greece, Tunisia, California) — blends from multiple countries are often lower quality
Third-party certification (PDO, PGI, COOC, NAOOA seal) — addresses ongoing industry adulteration
Polyphenol content >250 mg/kg if listed — strongest EU health-claim oils are 500+ mg/kg

Be skeptical of

'Light' or 'pure' olive oil — these are refined and contain little hydroxytyrosol
'Olive pomace oil' — solvent-extracted from the leftover paste; not the same product
No harvest date or 'best by' more than 24 months out — likely old stock
Bargain prices significantly below market for genuine EVOO — adulteration risk is high
Generic plastic bottles in clear glass — promotes oxidation

References by claim

Cardiovascular disease prevention (within Mediterranean diet)

Estruch et al., 2018New England Journal of Medicine — PREDIMED reanalysis (2018) link

Guasch-Ferré et al., 2014BMC Medicine (PREDIMED olive oil cohort) (2014) link

LDL cholesterol oxidation and lipid profile

EFSA Panel on Dietetic Products, 2011EFSA Journal — health claim on olive oil polyphenols (2011) link

Safety

USDA FoodData Central — Olive OilUSDA Agricultural Research Service (2024) link

Other references

Olive oil on WikidataWikidata link

Olive Oil on NIH DSLDNIH Dietary Supplement Label Database link

Track Olive Oil with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.